We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Perspectives and challenges of small molecule inhibitor therapy for FLT3-mutated acute myeloid leukemia

    Acute myeloid leukemia (AML) is a heterogeneous clonal disease characterized overall by an aggressive clinical course. The underlying genetic...

    Coen J Lap, Marwa SH Abrahim, Samah Nassereddine in Annals of Hematology
    Article 17 November 2023
  2. A small molecule inhibitor of the UBE2F-CRL5 axis induces apoptosis and radiosensitization in lung cancer

    Protein neddylation is catalyzed by a neddylation activating enzyme (NAE, E1), an E2 conjugating enzyme, and an E3 ligase. In various types of human...

    Tiantian Xu, Qisheng Ma, ... Yi Sun in Signal Transduction and Targeted Therapy
    Article Open access 17 October 2022
  3. Antitumor effect of a small-molecule inhibitor of KRASG12D in xenograft models of mucinous appendicular neoplasms

    Pseudomyxoma peritonei (PMP) is a rare disease characterized by a massive accumulation of mucus in the peritoneal cavity. The only effective...

    Mari C. Vázquez-Borrego, Melissa Granados-Rodríguez, ... Álvaro Arjona-Sánchez in Experimental Hematology & Oncology
    Article Open access 08 December 2023
  4. Gp130 is expressed in pancreatic cancer and can be targeted by the small inhibitor molecule SC144

    Purpose

    Interleukin 6 (IL-6), Oncostatin M (OSM), and downstream effector STAT3 are pro-tumorigenic agents in pancreatic ductal adenocarcinoma (PDAC)....

    Ioannis Pozios, Nina A. Hering, ... Hendrik Seeliger in Journal of Cancer Research and Clinical Oncology
    Article Open access 10 December 2022
  5. A combination of novel NSC small molecule inhibitor along with doxorubicin inhibits proliferation of triple-negative breast cancer through metabolic reprogramming

    Treatment of patients with triple-negative breast cancer (TNBC) has been challenging due to the absence of well-defined molecular targets and the...

    Hassan Yousefi, Maninder Khosla, ... Suresh K. Alahari in Oncogene
    Article 15 October 2022
  6. Targeting PELP1 oncogenic signaling in TNBC with the small molecule inhibitor SMIP34

    Purpose

    Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer. Oncogenic PELP1 is frequently overexpressed in TNBC, and...

    Kristin A. Altwegg, Uday P. Pratap, ... Ratna K. Vadlamudi in Breast Cancer Research and Treatment
    Article Open access 18 May 2023
  7. Characterization of a small-molecule inhibitor targeting NEMO/IKKβ to suppress colorectal cancer growth

    NEMO/IKKβ complex is a central regulator of NF-κB signaling pathway, its dissociation has been considered to be an attractive therapeutic target....

    Zhenlong Yu, Jian Gao, ... **aochi Ma in Signal Transduction and Targeted Therapy
    Article Open access 09 March 2022
  8. The Safety, Pharmacokinetics, and Pharmacodynamics of SHR2285, an Oral Small Molecule Factor XIa Inhibitor, in Healthy Chinese Volunteers

    Background and Objective

    There is an unmet need for a safer anticoagulant since bleeding remains a concern with currently approved anticoagulants....

    Junyu Xu, Nan Zhao, ... Yimin Cui in Clinical Drug Investigation
    Article 16 June 2023
  9. A small-molecule pan-HER inhibitor alone or in combination with cisplatin exerts efficacy against nasopharyngeal carcinoma

    The abnormal activation of HER family kinase activity is closely related to the development of human malignancies. In this study, we used HER kinases...

    **g Yang, Yanfei Yang, ... **awei Wei in Frontiers of Medicine
    Article 16 January 2023
  10. Small molecule heat shock protein 27 inhibitor J2 decreases ovarian cancer cell proliferation via induction of apoptotic pathways

    Heat shock protein 27 (Hsp27) is an important member of the chaperone protein family and its overexpression promotes cancer cell survival. Here, we...

    Dilay Karademir, Aykut Özgür in Medical Oncology
    Article 26 July 2023
  11. Update on Small Molecule Targeted Therapies for Acute Myeloid Leukemia

    The search for effective therapies for the highly heterogenous disease acute myeloid leukemia (AML) has remained elusive. While cytotoxic therapies...

    Jiasheng Wang, Benjamin Tomlinson, Hillard M. Lazarus in Current Treatment Options in Oncology
    Article 17 May 2023
  12. A small molecule inhibitor of VSIG-8 prevents its binding to VISTA

    The V-region immunoglobulin-containing suppressor of T cell activation (VISTA), a unique B7 family member, is an attractive immunotherapeutic target...

    Wenting Chen, Chenxin Qie, ... Jun Liu in Investigational New Drugs
    Article 11 April 2022
  13. Small molecule inhibitors targeting m6A regulators

    As the most common form of epigenetic regulation by RNA, N 6 methyladenosine (m 6 A) modification is closely involved in physiological processes, such...

    Guotai Feng, Yongya Wu, ... Guan Wang in Journal of Hematology & Oncology
    Article Open access 06 May 2024
  14. Small-molecule anti-COVID-19 drugs and a focus on China’s homegrown mindeudesivir (VV116)

    The coronavirus disease 2019 (COVID-19) pandemic has stimulated tremendous efforts to develop therapeutic agents that target severe acute respiratory...

    Qiuyu Cao, Yi Ding, ... Ren Zhao in Frontiers of Medicine
    Article 01 December 2023
  15. Efficacy and safety study of targeted small-molecule drugs in the treatment of systemic lupus erythematosus

    Background

    Targeted small-molecule drugs in the treatment of systemic lupus erythematosus (SLE) have attracted increasing attention from clinical...

    Shiheng Wang, Wanling Ning, ... **aosong Huang in Arthritis Research & Therapy
    Article Open access 10 May 2024
  16. Application of physiologically based pharmacokinetics modeling in the research of small-molecule targeted anti-cancer drugs

    Introduction

    Physiologically based pharmacokinetics (PBPK) models are increasingly used in the drug research and development, especially in...

    **aowen Wang, Fang Chen, ... Bing Han in Cancer Chemotherapy and Pharmacology
    Article 19 July 2023
  17. Small-molecule amines: a big role in the regulation of bone homeostasis

    Numerous small-molecule amines (SMAs) play critical roles in maintaining bone homeostasis and promoting bone regeneration regardless of whether they...

    Qian Zhang, Jirong Yang, ... Changshun Ruan in Bone Research
    Article Open access 24 July 2023
  18. Small-Molecule Compounds Boost CAR-T Cell Therapy in Hematological Malignancies

    Although chimeric antigen receptor T cell immunotherapy has been successfully applied in patients with hematological malignancies, several obstacles...

    ** Cao, **n **, ... Mingfeng Zhao in Current Treatment Options in Oncology
    Article Open access 26 January 2023
  19. Small molecule inhibitors of the VEGF and tyrosine kinase for the treatment of cervical cancer

    Cervical cancer accounts for most deaths due to cancer in women, majorly in develo** nations. The culprit behind this disease is the human...

    Fatima Sarwar, Samreen Ashhad, ... Reena Vishvakarma in Medical Oncology
    Article 10 July 2024
Did you find what you were looking for? Share feedback.